Anxiety, anxiolytics and brain stimulation reinforcement

Area of Science:

• Neuroscience
• Psychopharmacology
• Anxiety Research

Background:

• Anxiety's neuronal substrates are investigable using brain stimulation.
• Anxiolytics like benzodiazepines may enhance intracranial self-stimulation (ICSS).
• Variability in ICSS effects is partly due to sedative/muscle relaxant properties.

Purpose of the Study:

• To review how brain stimulation techniques elucidate the neuronal basis of anxiety.
• To analyze the mechanisms by which anxiolytics affect ICSS behavior.
• To propose an integrated strategy for anxiety research combining brain stimulation and molecular approaches.

Main Methods:

• Review of studies using brain stimulation techniques (e.g., ICSS) to investigate anxiety.
• Analysis of anxiolytic drug effects (meprobamate, benzodiazepines, barbiturates, inverse agonists) on ICSS and escape behaviors.
• Examination of the dissociation between sedative effects and ICSS enhancement.

Main Results:

• Anxiolytics enhance ICSS primarily by attenuating aversive stimulation, not via sedative effects.
• Anxiolytic drugs reduce centrally mediated escape from aversive dorsal tegmental stimulation.
• Inverse benzodiazepine agonists attenuate ICSS without necessarily increasing stimulation aversiveness.

Conclusions:

• Brain stimulation is a viable method for studying anxiety's neural mechanisms.
• Anxiolytics modulate ICSS by reducing aversion, with distinct mechanisms for benzodiazepines and barbiturates.
• Integrating brain stimulation with molecular techniques can advance understanding of anxiety and its regulation.